Frazier Financial Advisors, LLC Bio N Tech Se Transaction History
Frazier Financial Advisors, LLC
- $129 Billion
- Q3 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 262 shares of BNTX stock, worth $30,690. This represents 0.02% of its overall portfolio holdings.
Number of Shares
262
Previous 265
1.13%
Holding current value
$30,690
Previous $21.3 Million
46.12%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
359Shares Held
38.4MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.22MShares$963 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$529 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$516 Million2.03% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$222 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$212 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...